These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 29421536)
1. SIRT3 inhibits prostate cancer metastasis through regulation of FOXO3A by suppressing Wnt/β-catenin pathway. Li R; Quan Y; Xia W Exp Cell Res; 2018 Mar; 364(2):143-151. PubMed ID: 29421536 [TBL] [Abstract][Full Text] [Related]
2. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells. Liu H; Yin J; Wang H; Jiang G; Deng M; Zhang G; Bu X; Cai S; Du J; He Z Cell Signal; 2015 Mar; 27(3):510-8. PubMed ID: 25578861 [TBL] [Abstract][Full Text] [Related]
3. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression. Lee SC; Kim OH; Lee SK; Kim SJ Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645 [TBL] [Abstract][Full Text] [Related]
4. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851 [TBL] [Abstract][Full Text] [Related]
5. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha. Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532 [TBL] [Abstract][Full Text] [Related]
6. Wogonoside Inhibits Prostate Cancer Cell Growth and Metastasis via Regulating Wnt/β-Catenin Pathway and Epithelial-Mesenchymal Transition. Wei C; Jing J; Zhang Y; Fang L Pharmacology; 2019; 104(5-6):312-319. PubMed ID: 31480051 [TBL] [Abstract][Full Text] [Related]
7. β-ionone Inhibits Epithelial-Mesenchymal Transition (EMT) in Prostate Cancer Cells by Negatively Regulating the Wnt/β-Catenin Pathway. Fang Q; Que T; Liu B; Dan W; Wei Y; Ren B; Fan Y; Hou T; Zeng J Front Biosci (Landmark Ed); 2022 Dec; 27(12):335. PubMed ID: 36624947 [TBL] [Abstract][Full Text] [Related]
8. Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling. Liu Y; Qin Z; Yang K; Liu R; Xu Y Oncol Rep; 2017 Mar; 37(3):1521-1528. PubMed ID: 28098905 [TBL] [Abstract][Full Text] [Related]
9. Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling. Nath D; Li X; Mondragon C; Post D; Chen M; White JR; Hryniewicz-Jankowska A; Caza T; Kuznetsov VA; Hehnly H; Jamaspishvili T; Berman DM; Zhang F; Kung SHY; Fazli L; Gleave ME; Bratslavsky G; Pandolfi PP; Kotula L Cell Commun Signal; 2019 Sep; 17(1):120. PubMed ID: 31530281 [TBL] [Abstract][Full Text] [Related]
10. MUC15 loss facilitates epithelial-mesenchymal transition and cancer stemness for prostate cancer metastasis through GSK3β/β-catenin signaling. Wu S; Yue Y; Gu Y; Wang Q; Liu T; Li L; Wang X; Chang LS; He D; Wu K Cell Signal; 2021 Aug; 84():110015. PubMed ID: 33894313 [TBL] [Abstract][Full Text] [Related]
11. FOXO3a knockdown promotes radioresistance in nasopharyngeal carcinoma by inducing epithelial-mesenchymal transition and the Wnt/β-catenin signaling pathway. Luo M; Wu C; Guo E; Peng S; Zhang L; Sun W; Liu D; Hu G; Hu G Cancer Lett; 2019 Jul; 455():26-35. PubMed ID: 31022422 [TBL] [Abstract][Full Text] [Related]
12. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity. Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329 [TBL] [Abstract][Full Text] [Related]
13. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells. Huang J; Xiao D; Li G; Ma J; Chen P; Yuan W; Hou F; Ge J; Zhong M; Tang Y; Xia X; Chen Z Oncogene; 2014 May; 33(21):2737-47. PubMed ID: 23752181 [TBL] [Abstract][Full Text] [Related]
14. Silencing effects of FOXD1 inhibit metastatic potentials of the PCa via N-cadherin - Wnt/β-catenin crosstalk. Donmez C; Konac E Gene; 2022 Aug; 836():146680. PubMed ID: 35738443 [TBL] [Abstract][Full Text] [Related]
15. Agkihpin, a novel SVAE may inhibit the migration and invasion of liver cancer cells associated with the inversion of EMT induced by Wnt/β-catenin signaling inhibition. Huang M; Wu S; Hu Q; Wu H; Wei S; Xie H; Sun K; Li X; Fang L Biochem Biophys Res Commun; 2016 Oct; 479(2):283-289. PubMed ID: 27644877 [TBL] [Abstract][Full Text] [Related]
16. Adjudin synergizes with paclitaxel and inhibits cell growth and metastasis by regulating the sirtuin 3-Forkhead box O3a axis in human small-cell lung cancer. Wang X; Zeng Q; Li Z; Yang X; Xia W; Chen Z Thorac Cancer; 2019 Apr; 10(4):642-658. PubMed ID: 30779316 [TBL] [Abstract][Full Text] [Related]
18. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer. Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341 [TBL] [Abstract][Full Text] [Related]
19. PRKAR2B promotes prostate cancer metastasis by activating Wnt/β-catenin and inducing epithelial-mesenchymal transition. Sha J; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W J Cell Biochem; 2018 Sep; 119(9):7319-7327. PubMed ID: 29761841 [TBL] [Abstract][Full Text] [Related]
20. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression. Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]